首页> 外文期刊>Continental Shelf Research: A Companion Journal to Deep-Sea Research and Progress in Oceanography >Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study
【24h】

Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study

机译:扩散加权成像作为评估鼻咽癌患者主要唾液腺功能的后续模态:初步研究

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose To investigate the value of diffusion-weighted imaging (DWI) in assessing dynamic changes of major salivary gland function during follow-up post radiotherapy (RT) in nasopharyngeal carcinoma (NPC) patients. Materials and methods 31 consecutive patients with pathologically confirmed NPC scheduled for RT underwent six routine follow-up MRI examinations including DWI sequence prior to (pre-RT) and 1, 3, 6, 9, and 12 months post RT. Mean apparent diffusion coefficient (ADC) values of bilateral parotid glands (PGs) and submandibular glands (SMGs) were measured. Objective measurement of salivary flow rate (SFR) under unstimulated (uSFR) and stimulated conditions (sSFR) as well as subjective xerostomia assessment according to a patient-rated questionnaire were conducted before each MRI. Variance analysis was used to evaluate dynamic changes of ADC, SFR and xerostomia questionnaire summary scores (XQ-sum) at different timepoints and the correlation between ADC and XQ-sum. Pearson's correlation test was used to evaluate the correlations between pre- and post-RT changes of ADC (Delta ADC) and SFR (Delta SFR) or mean RT dose. Results At each timepoint, ADCs of PGs were significantly lower than of SMGs, uSFR was significantly lower than sSFR. For both PGs and SMGs, ADC(post-RT) were all higher than ADC(pre-RT), with significant differences. ADC(1m-post-RT) initially increased and changed little to ADC(3m-post-RT), ADC(6m-post-RT), ADC(9m-post-RT), and ADC(12m-post-RT), then gradually declined over time. The dynamic change trends of SFR were negatively paralleled to those of ADC, while that of XQ-sum was similar. Dose-response relationships were detected between salivary gland mean RT dose and Delta ADC. In PGs, negative correlations between Delta sSFR(9m-post-RT) and Delta ADC(9m-post-RT), and Delta sSFR(12m-post-RT) and Delta ADC(12m-post-RT) were detected. In SMGs, negative correlations between Delta sSFR(12m-post-RT) and Delta ADC(12m-post-RT), and Delta uSFR(12m-post-RT) and Delta ADC(12m-post-RT) were also detected. The ADCs of patients with severe subjective xerostomia were significantly higher, while patients with moderate subjective xerostomia presented a tendency toward higher ADCs compared to those with mild xerostomia from 6 to 12 months post RT. Conclusion As part of routine follow-up MRI in NPC patients, DWI might be a promising modality for follow-up assessing the dynamic changes of major salivary gland function and might be more powerful in the late post-RT period.
机译:目的探讨扩散加权成像(DWI)在评估鼻咽癌(NPC)患者的后续放射治疗(RT)期间评估主要唾液腺功能的动态变化。材料和方法31连续患者病理证实的NPC预定进行RT的六个常规后续MRI检查,包括在RT之前(RT)和1,3,6,9和12个月之前的DWI序列。测量双侧腮腺(PGS)和潜水腺(SMG)的平均表观扩散系数(ADC)值。在每个MRI之前进行了未受刺激(USFR)和刺激条件(SSFR)和刺激条件(SSFR)以及主观Xerostomia评估的客观测量。方差分析用于评估ADC,SFR和Xerostomia调查问卷摘要分数(XQ-SUM)的动态变化,以及ADC和XQ-SUM之间的相关性。 Pearson的相关性试验用于评估ADC(Delta ADC)和SFR(Delta SFR)的前后变化与RT变化的相关性或意味着RT剂量。结果在每个时间点,PGS的ADC显着低于SMG,USFR显着低于SSFR。对于PGS和SMG而言,ADC(RT)均高于ADC(RT),具有显着差异。 ADC(1M-POST-RT)最初增加并少于ADC(RT),ADC(6m-Post-RT),ADC(9M-POST-RT)和ADC(12M-POST-RT)而变化然后随着时间的推移逐渐下降。 SFR的动态变化趋势与ADC的那些对ADC的负面相似,而XQ-SUM的趋势相似。唾液腺意味着RT剂量和DELTA ADC之间检测剂量 - 反应关系。在PGS中,检测DELTA SSFR(9M-PHERT)和DELTA ADC(9M-PHORT-RT)和DELTA SSFR(12M-PHERT)和DELTA ADC(12M-后RT)之间的负相关性。在SMG中,还检测到δSSFR(12M-后)和Delta ADC(12M-PHER-RT)和DELTA USFR(12M-PHERT-RT)和DELTA ADC(12M-后RT)之间的负相关性。严重主观挠性阳瘤患者的ADC显着升高,而中等主观Xerostomia的患者相比,与Rt的6至12个月,患有温和Xerostomia的患者呈现出更高的ADC。结论作为NPC患者常规后续MRI的一部分,DWI可能是一个有前途的方式,用于评估主要唾液腺功能的动态变化,在后期的后期可能更强大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号